SaveOnSP FPh White Paper
The dramatic rise in specialty medications has made new and valuable treatment options available for patients living with complex, chronic conditions like cancer, rheumatoid arthritis, multiple sclerosis, and rare diseases. However, there has been a significant economic impact due to the growing specialty medication market and the high costs associated to specialty medications. Paired with pharma’s market commercialization strategies, employers, insurers, and patients are struggling to afford these therapies.
In this overview, we will discuss the continually expanding specialty market, highlight certain cost drivers and market dynamics, and provide insight on solutions for managing the cost of specialty medications. We will highlight the key differences between an accumulator adjustment program and a copay maximizer program, outlining key differentiating features of the SaveOnSP solution.